Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 26, 2024
Oncology Center of Excellence Center for Biologics Evaluation and Research Center for Drug Evaluation and Research Office of the Commissioner,Office of Minority Health and Health Equity Office of the Commissioner,Office of Women's Health
3636af78-19ca-4bf0-a4ed-da9425a55b4f
Related Documents
Screening Tests Prior to Study Enrollment: Guidance for Institutional Review Boards and Clinical Investigators
Guidance DocumentJanuary 1, 1998
Payment and Reimbursement to Research Subjects: Guidance for Institutional Review Boards and Clinical Investigators
Guidance DocumentJanuary 29, 2018
Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials
Guidance DocumentFebruary 4, 2010
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.